Style | Citing Format |
---|---|
MLA | Momenzadeh M, Khosravian M, Lakkakula BVKS. "Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders." Journal of Nephropharmacology, vol. 10, no. 2, 2021, pp. -. |
APA | Momenzadeh M, Khosravian M, Lakkakula BVKS (2021). Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders. Journal of Nephropharmacology, 10(2), -. |
Chicago | Momenzadeh M, Khosravian M, Lakkakula BVKS. "Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders." Journal of Nephropharmacology 10, no. 2 (2021): -. |
Harvard | Momenzadeh M, Khosravian M, Lakkakula BVKS (2021) 'Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders', Journal of Nephropharmacology, 10(2), pp. -. |
Vancouver | Momenzadeh M, Khosravian M, Lakkakula BVKS. Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders. Journal of Nephropharmacology. 2021;10(2):-. |
BibTex | @article{ author = {Momenzadeh M and Khosravian M and Lakkakula BVKS}, title = {Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders}, journal = {Journal of Nephropharmacology}, volume = {10}, number = {2}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Momenzadeh M AU - Khosravian M AU - Lakkakula BVKS TI - Potential of Renin-Angiotensin System Inhibition to Improve Metabolic Bone Disorders JO - Journal of Nephropharmacology VL - 10 IS - 2 SP - EP - PY - 2021 ER - |